Extracorporeal membrane oxygenation for refractory COVID-19 acute respiratory distress syndrome
- PMID: 32731100
- PMCID: PMC7365051
- DOI: 10.1016/j.jcrc.2020.07.013
Extracorporeal membrane oxygenation for refractory COVID-19 acute respiratory distress syndrome
Keywords: Acute respiratory distress syndrome; COVID-19; Extracorporeal membrane oxygenation.
Conflict of interest statement
Declaration of Competing Interest AC reported receiving grants and personal fees from Getinge and Baxter; he was president of EuroELSO and is a member of the executive and scientific committees of the International ECMO Network (ECMONet). JDR received travel support form Fisher and Paykel Healthcare. DR received personal fees from Astellas. The other authors have no conflict of interests.
References
-
- Goligher E.C., Tomlinson G., Hajage D., Wijeysundera D.N., Fan E., Jüni P. Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome and posterior probability of mortality benefit in a post hoc Bayesian analysis of a randomized clinical trial. JAMA. 2018;320:2251–2259. doi: 10.1001/jama.2018.14276. - DOI - PubMed